best supplements for semaglutide + B6 | Boston Frequently Asked Questions | RYBELSUS®

Start gradually and increase activity as fitness improves

A 2025 RAND Corporation survey of nearly 9,000 Americans found that 11.8% of US adults have used a GLP-1 medication for weight loss or diabetes, and by late 2025 consumer tracking firm Circana was reporting that nearly a quarter of all US households have at least one person actively using these drugs

Individual response varies, and no specific result can be guaranteed

These are FDA-approved formulations of semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound)

The drug is an insulin regulator for diabetics, made by the Danish pharma juggernaut Novo Nordisk, whose primary side effect is dramatic weight loss

Weighing In on Obesity and Psoriatic Arthritis Time to Move Beyond Association to Robust Randomised Trials